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ABSTRACT
Advances in percutaneous coronary intervention (PCI) and peri-procedural potent antithrombotic treatments during the 
past decade have dramatically improved the outcomes of ischemic heart disease. The femoral artery is the vascular route used 
in PCI in most catheterization labs. However, when the femoral artery is used as the approaching vessel, local hemorrhagic 
complication is not rare in the era of potent antithrombotics. Recent studies have suggested that peri-procedural bleeding 
complications after PCI are associated with increased short- and long-term morbidity and mortality. On the other hand, there 
has been growing interest in transradial PCI due to rare complications at the puncture site, patient conveniences, early disch-
arge and shortened hospitalization periods. Furthermore, the indications of transradial PCI are expanding to the complex 
lesion subsets due to the miniaturization of devices used, improvement of devices and techniques, and accumulated experience 
with the use of transradial PCI. In this review, we discuss the data of transradial PCI as a potential default route in coronary 
artery interventions, as well as other issues that may raise concerns with transradial PCI. (Korean Circ J 2011;41:1-8)
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 Introduction
Femoral approach has been the preferred vascular access 
for coronary angiography and percutaneous coronary inter-
vention (PCI). However, recent reports have suggested that 
the radial artery approach for coronary angiography and in-
terventions might be effective in terms of procedural out-
comes compared to transfemoral approach and permits a wide 
range of diagnostic and therapeutic interventions. Further-
more, the transradial approach is a very safe alternative to fe-
moral access due to a low rate of vascular entry site complica-
tions.
1-3) 
In the recent era of potent antiplatelet and anticoagulant th-
erapy, post-PCI bleeding complications are closely related 
with an increase of in-hospital outcomes, as well as mid- and 
long-term mortality.
4)5) Transradial coronary intervention (TRI) 
is an attractive access site for interventionists, compared to 
transfemoral coronary intervention (TFI), when considering 
the reduction of bleeding complications. 
Transradial vs. Transfemoral  
Coronary Intervention 
Efficacy of clinical outcomes
Although the amount of existing data comparing outcome 
after femoral and radial PCI is modest, a recent meta-analysis 
of 23 randomized trials showed that there were no significant 
differences in death, myocardial infarction (MI), or stroke be-
tween the transradial and transfemoral approach (TFI).
6) How-
ever, the mortality rate tends to be lower in the transradial 
group [mortality rate: 1.2% vs. 1.8%, for TRI vs. TFI, odds ratio 
(OR): 0.74 {95% confidence interval (CI) 0.42-1.30}, p=0.29]. 
The rates of MI and stroke individually were both similar to 
the trend seen in mortality {MI: 2.0% vs. 2.9% for TRI vs. 
TFI, OR 0.76 (95% CI 0.49-1.17), p=0.21} {Stroke: 0.1% vs. 
0.5% for TRI vs. TFI, OR 0.39 (95% CI 0.09-1.75), p=0.22}. 
When the three individual hard outcomes were combined, 
there was a marginal trend toward lower composite event rates 
in the transradial group {2.5% vs. 3.8%, (95% CI 0.49-1.01), 2   Transradial PCI as a Default Route 
p=0.058}.
6) The large cohort data from 593,094 procedures 
in the National Cardiovascular Data Registry (606 sites; 2004 
to 2007) were compared to the procedural success rate be-
tween TFI and TRI. Although the proportion of TRI proce-
dures are rare {1.32% (7,804 cases) of total procedure}, TRI 
was associated with a similar rate of procedural success {ad-
justed OR: 1.02 (95% CI: 0.93-1.12)} compared with TFI.
7) In 
a recent meta-analysis of acute MI performed primary PCI 
(n=3,324), there was significant reductions in the composite 
of death, MI, and stroke {3.65% vs. 6.55%, for TRI vs. TFI, OR 
0.56 (95% CI 0.39-0.79)}.
8)
Therefore, considerable evidence suggested that TRI has a 
similar procedural success and trend for reduction in ischemic 
events in coronary intervention compared with those of TFI. 
Bleeding and access site complications
Post-PCI bleeding complications are most commonly relat-
ed to vascular access of the femoral artery. Femoral bleeding 
complications have traditionally been considered benign. How-
ever, the Mayo clinic data of 17,901 patients who underwent 
PCI between 1995 and 2006 found that major femoral bl-
eeding complications were associated with increased 30-day 
mortality with a adjusted hazard ratio of 9.96 (95% CI: 6.94-
14.3).
4) Similar findings of a national cohort study showed that 
access site hematoma requiring transfusion independently 
associated with in-hospital mortality (OR 3.59, 95% CI 1.66-
7.77) and 1-year death (OR 1.65, 95% CI 1.01-2.70).
5) Current-
ly, available data suggests that access site complications are not 
a benign complication of PCI, but a very important predic-
tor of adverse procedural success and patient outcome.
A definite advantage of the transradial approach is the re-
duction in access site related complications such as access site 
bleeding, pseudoaneurysm, and arteriovenous fistula.
1)7)8) In 
the meta-analysis of 23 randomized trials, radial access reduc-
ed the OR of major bleeding by 73% in patients undergoing 
coronary angiography or intervention compared to femoral 
access.
6) These benefits can be explained by the fact that the 
radial artery runs superficially and hemostasis can be easily 
achieved by manual compression or pressure bandage. In addi-
tion, no major nerves or veins were located near the radial ar-
tery, minimizing the risk of injury of these structures. 
Some studies have shown that TRI could reduce both the bl-
eeding complication and clinical outcomes. In the Mortality 
benefit Of Reduced Transfusion after percutaneous coronary 
intervention via the Arm or Leg (M.O.R.T.A.L) study from 
38,872 PCI patients (radial approach, 20.5%), TRI was asso-
ciated with a significant decrease in bleeding complications 
{OR 0.59 (95% CI 0.48 to 0.73)}, 30-day mortality {OR 0.71 
(95% CI 0.61-0.82)} and 1-year mortality {OR 0.83 (95% CI 0.71- 
0.98)}, compared with those of TFI.
9) In the meta-analysis with 
ST elevation MI, TRI reduces the risk of peri-procedural ma-
jor bleeding {OR 0.30 (95% CI 0.16-0.55)}, and mortality {OR 
0.54 (95% CI 0.33-0.86)} in the primary PCI setting.
8) How-
ever, clinical evidence is limited because most of the study was 
observational or the data was obtained from an experienced 
operator. Therefore, large randomized clinical trials (RCT) 
are necessary to determine the benefit of TRI from access site 
bleeding to mortality and several large scale RCTs are ongoing 
(ClinicalTrials.gov Identifier; NCT01014273).
Another advantage of TRI is that it leads to early ambula-
tion and may result in reduced hospital stay and decreased 
cost.
10) Therefore, experienced centers of TRI establish an 
outpatient PCI unit, leading to increased turnover of PCI and 
diagnostic angiography cases and reduced cost for hospital 
stay.
10)11) Many interventional cardiologists are becoming in-
creasingly interested in TRI due to rare access site hematoma, 
patient convenience, and shortened hospitalization periods.
Downside of transradial procedures
Although less procedural complications leads to an impro-
vement of procedural outcomes, there are also downsides to 
the transradial approach. The transradial approach was asso-
ciated with a significantly longer procedural time (mean dif-
ference: 3.1 minutes in meta-analysis) and fluoroscopic time 
(mean difference: 0.1 minutes in meta-analysis).
6) However, 
there was significant heterogeneity (p<0.001, i
2=87%) with a 
large difference in procedural time in studies performed by 
non-TRI experts {4.8 minutes (95% CI 3.7-5.8 minutes)} com-
pared to TRI experts {1.7 minutes (95% CI 0.7-2.6 minutes)} 
suggesting that a significant learning curve is present.
6) 
A major problem in the early period may be access failure 
leading to crossover to another puncture site. In a recent meta-
analysis, the rate of access site crossover was significantly hi-
gher with the TRI (5.9%, 150 of 2,542 patients) compared with 
the TFI (1.4%, 34 of 2,460 patients) {OR 3.82 (95% CI 2.83-
5.15), p<0.001}.
6) However, the OR for access site crossover 
decreased significantly from the earlier period of radial access 
to the modern period, suggesting that improvements in device 
technology and increase in expertise have narrowed the gap. 
Another technical issue is related to the size of the guide ca-
theter because the diameter of the radial artery is smaller than 
that of the femoral artery. In a meta-analysis, there was a slight 
insignificant trend towards higher failure rate of crossing le-
sion with wire, balloon, or stent with the transradial approach 
{OR 1.31 (95% CI 0.87-1.96), p=0.20}. However, in the studies 
performed by radial experts, the rates were similar between 
TRI and TFI {OR: 1.18 (95% CI 0.77-1.81), p=0.44}, again sug-
gesting the presence of a learning curve.
6) Overcoming the 
learning curve is usually dependant on TRI cases and an an-
nual procedural volume >80 transradial cases are significant 
reductions in access failure, sheath insertion time, and overall 
procedural time in an observation study.
12) With the develop-
ment of dedicated catheters such as the sheathless system for 
TRI and with increased experience, there seem to be similar Jang-Young Kim, et al.   3
in access failure and procedure times between TRI and TFI.
In summary, TRI is associated with comparable procedural 
success and efficacy to TFI and reduces access site related com-
plications and has made early ambulation possible, which sig-
nificantly increases patient comfort and reduced hospital stay 
and cost. Therefore, TRI is a very attractive technique to apply 
in daily practice as a default route. 
Concerned Issues of Transradial 
Coronary Intervention 
as a Default Route
The indications of transradial PCI are expanding complex co-
ronary lesions {e.g., chronic total occlusion (CTO),
13)14) primary 
PCI,
8)15)16) and bifurcation lesion
17)} and non-coronary angio-
plasty (e.g., renal artery stenosis
18) and peripheral artery disease
19)) 
due to the miniaturization of devices used, improvement of 
devices, and accumulated experience with transradial PCI. 
Although TRI has many advantages over TFI during inter-
ventional procedures, <10% of cath. labs use TRI as a default 
route.
7)20) There are some obstacles to overcome the learning 
curve related to the radial artery access, selection of guide ca-
theter and complex lesion angioplasty. 
Issues related to the radial artery access 
Puncture failure is the first obstacle during the early learning 
period of TRI because radial artery is small (less than 4 mm) 
and prone to arterial spasm. In our experience, the wrist pain 
at the puncture site is an important factor leading to radial 
spasm and puncture failure. Premedication should be given, 
such as a light sedative or local anesthetic cream. Eutectic mix-
ture of local anesthetic (EMLA) cream, composed of lidocaine 
2.5% and prilocaine 2.5%, is known to be an effective topical 
anesthetic agent. It is used for a variety of painful cutaneous 
procedures on intact skin, including phlebotomy, intravenous 
catheterization, arterial cannulation and lumbar puncture.
21) 
In our data, EMLA cream was able to reduce the pain (about 
half) during transradial cannulation and reducing the rate 
of puncture failure (Fig. 1).
22) After sheath insertion, spasmo-
lytic cocktails (various combinations of nitrate, xylocaine and 
verapamil) have been proposed to reduce the radial artery sp-
asm during the procedures. 
Variations and tortuosity of the radial artery have been ob-
served during human dissections and on angiographic images. 
In routine clinical practice, variations of these vessels are one 
of the main reasons for technical difficulty and failure in 
TRI. In our data,
23) tortuosity of radial and brachial artery was 
found in 4.2% (67 cases of 1,191 cases) and more frequently 
in elderly persons. The most common forms of tortuosity were 
S-shape in 21 cases, omega-shape in 21 cases and alpha-sh-
ape (radial artery loop) in 6 cases. In addition, the most com-
mon site of radial artery tortuosity was proximal third of an-
tecubital fossa. Prolonged procedure times and/or cross-over 
to other routes were related with tortuosity of the radial ar-
tery (especially, omega and alpha-shape). However, the over-
all incidence of cross-over due to severe tortuosity of radial and 
brachial artery is rare (less than 1%) in our study.
23) 
Local vascular complications of TRI are rare compared to 
the femoral approach. The most frequent complication dur-
ing TRI is the radial artery spasm as previously described. 
The other rare complications are severe hematoma or com-
partment syndrome due to small branch perforation of con-
duit artery and bleeding,
24) radial artery occlusion,
25) AV fis-
tula (very rare), and causalgia caused by nerve injury during ar-
terial puncture. Radial artery occlusion accounts for about 1% 
of transradial procedures. Most patients with radial artery oc-
clusion are asymptomatic due to dual supply of the ulnar-ra-
dial artery. The use of an adequate amount of heparin is im-
portant in the prevention of radial artery occlusion after the 
procedure. The use of a standard 5,000 IU (relatively high do-
sage of transradial diagnostic procedure) or 50 U/kg of hep-
arin is recommended.
26) 
A-V fistula is an extremely (<0.1%) rare situation that can 
arise after transradial procedures. Usually, they are asympto-
matic with incidental accounts of bruit of puncture site. Ra-
dio-ulnar fistula can infrequently be corrected by surgery. 
Severe bleeding in the forearm or compartment syndrome 
is a rare condition (<0.4%) after TRI procedures. The patient 
has symptoms of pain, pallor, painful stretching of muscle, 
paresthesia, and pulseless of forearms. Forearm bleeding can 
usually be observed after compression and rarely needs sur-
gical intervention (surgical fasciotomy of forearm) due to 
ongoing ischemic changes of the forearm. Therefore, it is criti-
cal to immediately detect swellings of the access site or the 
path of catheter which are easily controlled with haemostatic 
compression.
Fig. 1. Application of eutectic mixture of local anesthetic cream on radial artery puncture site.4   Transradial PCI as a Default Route 
Right radial approach vs. left radial artery approach 
For selecting the vascular access site, most interventional 
cardiologists are familiar with doing the procedure at the right 
side of the patient since the right radial approach is more con-
venient for manipulating the devices, including the guide 
catheter. Therefore, almost 90% of interventional cardiologists 
select the right radial artery as a first access route when per-
forming transradial procedures in international survey data.
20) 
The only difference in performing the left radial access is 
that because the operator’s standing position is apart from 
the left arm, the operator must bend over the patient, which 
may be inconvenient to the operator (Fig. 2). However, there 
are several advantages in selecting the left radial approach in 
terms of patient comfort and the effectiveness of the proce-
dures. First, the left radial approach potentially increases pa-
tient comfort because most patients are right handed. The pa-
tients are free to use his/her right hand immediately after the 
procedure. Second, a left internal mammary angiogram can 
easily be performed in the case of a coronary artery bypass gr-
aft candidate. The advantages or disadvantages of right or left 
radial artery access are summarized in Table 1. 
Our institute retrospectively evaluated the procedural suc-
cess rate, crossover rate, puncture time, total procedural dura-
tion, fluoroscopy time, amount of contrast agent used and the 
local vascular complications in 711 cases via the left radial ap-
proach (Lt. group) and in 614 cases via the right radial appro-
ach (Rt. group).
27) The puncture time, amount of contrast agent 
used, choice of the guide catheter and local vascular complic-
ations were similar for the two groups. There was no differ-
ence in the procedural success rate (Lt. group; 96.2% vs. Rt. 
group; 96.4%, p=not significant). However, there was a tend-
ency towards a higher success rate via radial access for the Lt. 
group than for the Rt. group (Lt. group; 93.5% vs. Rt. group; 
91.9%, p=0.056). The crossover rate was lower for the Lt. 
group than for the Rt. group (2.7% vs. 4.6%, respectively; 
p=0.04). The total procedural time (30.7±17.6 minutes vs. 
32.3±15.4 minutes, respectively; p=0.03) and fluoroscopy 
time (13.9±7.9 minutes vs. 16.9±12.6 minutes, respectively; 
Fig. 2. Procedural position of the right and left radial approaches for coronary interventions. A: left radial approach. B: right radial approach.
A   B  
Table 1. Advantages and disadvantages of right vs. left radial artery approach 
Right radial artery approach during transradial procedures
Advantage
Convenience of operator 
Easy to puncture 
Disadvantage
Difficult to catheter manipulation due to subclavian artery tortuosity in 10% patients*
Total procedure time and fluoroscopy time: Sometimes longer than left approach
Left radial artery approach during transradial procedures
Advantage
Catheter selection & manipulation : similar to transfemoral intervention
Convenience of patient
Low frequency of severe tortuous subclavian artery
Easy to angiogram of left internal mammary artery  
Disadvantage
Discomfort of operator
Difficulty of puncture position 
sometimes, acute angle from left subclavian artery to aortic arch
*Higher frequency of severe subclavian artery tortuosity
29): Old age/Female/HTN/Small height/High body mass indexJang-Young Kim, et al.   5
p<0.01) were shorter in the Lt. group. The number of guide 
catheters used was higher in the Rt. group compared to the 
Lt. group (1.21±0.48 vs. 1.08±0.33, respectively, p=0.04). Our 
data suggested that the left radial approach may provide in-
creased procedural efficacy during transradial procedures. 
Similar findings published in a randomized control trial 
(TALENT study) demonstrated that the left radial approach 
for TRI is associated with lower fluoroscopy time and radia-
tion dose adsorbed by patients compared with the right ra-
dial approach, particularly in older patients.
28) At present, 
the choice of the right or left radial artery as an entry site de-
pends largely on operator preference. However, in case of hi-
gher frequency of right subclavian artery tortuosity (age >65, 
female, and short status <160 cm),
29) the left radial approach 
might be better that the wight radial approach. 
Selection of guiding catheter
Diagnostic and PCI catheters for transradial approach are 
similar to those used for transfemoral approach at present. Re-
cent advances in interventional device technology have pro-
vided miniaturization of the guiding catheter (GC). With the 
recent availability of 5 Fr. GC, dedicated shape GC and shea-
thless GC, the usefulness and indication of TRI will be ex-
panded. 
Guiding catheter selection for transradial coronary 
intervention 
In the international survey data (75 countries) for TRI, a large 
majority of operators prefer to use 6 Fr GC. Only approxima-
tely 10% of operators use 5 Fr. GCs for TRI of right coronary 
artery, and <10% use 5-Fr. GCs for TRI of left coronary artery.
20)
The selection of GC shapes depends on the site of coronary 
lesion in the survey data. For left coronary artery lesions, op-
erators routinely use standard extra back-up (EBU) GCs. The 
most popular GC is EBU catheter (30% of all cases) in the in-
ternational survey data.
20) Amplatz, Kimny or Multipurpose 
GCs are also used for left coronary artery lesions. Interesting-
ly, a significant number of operators still use less supportable 
GCs, such as Judkins left in 22.5% for left anterior descend-
ing artery lesions. For the right coronary lesions, the most po-
pular GC shape is the Judkins right in 70.2% of cases. Amp-
latz left GC provides backup support for right coronary ar-
tery intervention. Therefore, Amplatz left GC can be used in the 
concomitant procedure in both coronary interventions.
20)
 
New technology of guide catheters 
Recent advancements in the technology of manufacturing 
TRI devices have now enabled us to use 5 Fr GC. Dahm et 
al.
30) performed a randomized comparison of 6 Fr and 5 Fr 
GC by TRI to investigate procedural and clinical success 
rates and the rate of vascular access complications. TRI with 
5 Fr GC shows a trend in favor of a higher procedural success 
rate and a lower rate of vascular access complications com-
pared to 6 Fr GC, and these results were particularly marked in 
the subgroup of patients with small radial artery diameters.
Recently, the sheathless GC system (SheathLess Eaucath, 
Asahi Intecc
®, Japan) consists of a hydrophilic GC and a cen-
tral dilator. This system can be used to insert the GC into the 
Fig. 3. Comparison of outer diameter (OD) between introducer sheath and sheathless guiding catheters (Adapted from reference 31 with au-
thors’ permission).
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2.29 mm
7.5-Fr
Sheathless catheter
6-Fr
Introducer sheath
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radial artery without the use of an introducer sheath. The out-
er diameter of the 6.5 Fr sheathless GC (2.16 mm) is smaller 
than a 5 Fr introducer sheath (2.29 mm). The outer diameter 
of the 7.5 Fr sheathless GC (2.49 mm) is also less than that 
of 6 Fr introducer sheath (2.62 mm) (Fig. 3). With these fea-
tures, the sheathless GC system enables performance of TRI 
even in patients with a small radial artery diameter.
31) Further-
more, the hydrophilic coating that is present along the entire 
length of the GC may be helpful in reducing wrist pain due to 
arterial spasm. Mamas et al.
32) and Liang et al.
33) reported on 
successful use of a sheathless GC in complex interventions 
with large bore catheters including rotablation, crush stent bi-
furcation lesions, thrombectomy devices and simultaneous 
kissing stenting.
With the advancement of devices such as 5 Fr GC or sh-
eathless GC system, TRI will expand the indication of vari-
ous coronary lesion subsets and bulky device procedures with 
patient comfort, even for those with small radial artery size or 
spastic radial artery. 
Transradial coronary intervention for complex
lesions
The indications for TRI are expanding due to an accumula-
tion of experience with TRI and miniaturization of PCI de-
vices. TRI interventionists could be feasible to a complex le-
sion subset (e.g., CTO and bifurcation lesion PCI) and unstable 
patient’s haemodynamics (e.g., primary PCI and acute coro-
nary syndrome). Although there is limited data for TRI of a 
complex lesion subset with regards to efficacy and the safety, 
recent data demonstrates similar procedural results and re-
duced access site complications compare with TFI.
13-17)
Transradial coronary intervention for primary 
percutaneous coronary intervention
In the era of potent antiplatelets and anticoagulants to re-
duce the incidence of ischemic events, primary PCI should be 
associated with high access site bleeding complication in the 
usual transfemoral procedure.
34) Recent evidence showed that 
the burden of bleeding complications after primary PCI is clo-
sely related to the in-hospital morbidity and long term survi-
val.
8)35) Therefore, there are definite advantages of TRI in acu-
te MI if primary PCI via radial artery can be performed with 
equal feasibility as TFI. 
TEMPURA study showed that the success rate and major 
adverse cardiac events of transradial primary PCI were simi-
lar to transfemoral primary PCI, and hemorrhagic complic-
ations of transradial primary PCI including access site com-
plications were decreased.
15) In our data from 352 consecutive 
primary PCI cases,
16) vascular access time was similar (3.8± 
3.5 minutes in TFI and 3.6±3.1 minutes in TRI) and cath. 
room to reperfusion time was 25±11 minutes in TRI and 26± 
13 minutes in TRI. Procedural success rate was 89% in TFI gr-
oup and 88% in TRI group. Crossover occurred in 9 cases (4%) 
due to approaching vessel tortuosity in the TRI group. Major 
access site complication occurred in 7 cases (5%) in the TFI 
group and no complication in the TRI group (p<0.001). Alth-
ough radial occlusion occurred in 5 cases of the TRI group, 
there was no evidence of hand ischemia. The total hospital stay 
was significantly shorter in TRI than TFI group. These data show 
transradial primary PCI is an effective and safe route in acute 
MI settings. 
Recent meta-analysis (20 study involving 3,324 patients) 
confirms these findings.
8) TRI reduced major bleeding com-
pared to transfemoral PCI and significant reductions were 
found in the composite of death, MI, or stroke (p=0.001). Mor-
tality showed a significant trend towards benefit in the case 
of transradial primary PCI {2.04% vs. 3.06%, OR 0.54 (95% 
CI 0.33-0.86), p=0.01}. 
Collectively, transradial primary PCI reduces the risk of 
peri-procedural major bleeding and major adverse events with 
similar procedural success in the ST elevation acute MI settings. 
Transradial coronary intervention for chronic total 
occlusion
There is limited data available for comparing TRI and TFI 
in treatment of CTO. When the radial approach for CTO in-
tervention is attempted, availability of sufficient guiding sup-
port becomes a major concern since it is generally not feasi-
ble to use a GC larger than 7 Fr. Accordingly, the transfemoral 
approach is often preferred over transradial PCI for CTO be-
cause 7 or 8 Fr GCs may be used to obtain greater backup sup-
port, as compared to the 6 Fr GCs frequently used in the trans-
radial approach. 
However, several studies reported a high success rate for the 
transradial approach to CTO with acceptable crossover rate to 
femoral artery (3.3-6%).
13)14) Saito et al.
36) reported that the suc-
cess rate was 67% in phase 1 and this improved to 81% in ph-
ase 2 (late phase). During phase 2, the success rate was high-
er for patients who were treated with TRI rather than with TFI 
(89% vs. 64%; p=0.008) which may indicate that CTO inter-
vention is highly dependent on the experience and technique 
of the operators, regardless of access site. Rathore et al.
14) ex-
amined 468 patients who underwent CTO PCI and compar-
ed the TRI (318 patients) and TFI (150 patients). The procedu-
ral success rate was similar in both groups (82% radial and 86% 
femoral, p=0.28). Total fluoroscopy time, total procedure 
time, and total contrast volume were also similar in TFI and 
TRI. The incidence of death or MI remained low in both gr-
oups, but, not surprisingly, the rate of access site complications 
(3.5% of TRI vs. 11.3% of TFI) and hematoma >5 cm (0% of 
TRI vs. 2.6% of TFI) was significantly lower in the radial gr-
oup (p<0.001). 
Collectively, the radial artery is a feasible vascular access 
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complication and comparable procedural success as com-
pared with TFI. 
Transradial coronary intervention for bifurcation lesion 
Many interventionists prefer the TFI for bifurcation lesions 
because coronary bifurcation lesions usually need the larger 
GCs which accommodate two stents or two balloons. Recent 
advancement and miniaturization of interventional devices 
enables us to perform bifurcation stenting with 6 Fr large-lu-
men GCs or sheathless GCs in case of small radial artery size. 
To date, there are limited data sets on TRI for bifurcation le-
sions. 
In an observational study comparing immediate and 7- 
month follow-up clinical outcomes between TRI (n=60 pa-
tients) and TFI (n=74 patients) for true bifurcated lesions, 
there was no significant difference in immediate and long-
term clinical outcomes.
17)
Recently, the 7.5 Fr sheathless GC overcomes the lesions 
requiring simultaneous kissing stent implantation by tran-
sradial approaches. This sheathless system provides a large 
operating diameter and small outer catheter size compared to 
a conventional 6 Fr radial artery sheath introducer.
33) Collec-
tively, TRI of bifurcation lesion might be feasible, more effec-
tive and safer than TFI.
Conclusions
TRI was originally considered an alternative vascular route. 
However, due to technical improvements, enhanced device te-
chnology, and increased operator experience, TRI may be-
come a default vascular access route currently for diagnostic 
coronary angiography, elective coronary angioplasty, primary 
PCI in acute MI and complex lesion PCI including CTO 
and bifurcating lesion. 
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